Fact CheckerSign in

NCT07201857Not yet recruiting

Peri-habilitation for Patients With Gastric Cancer

Peri-habilitation to Enhance Treatment Outcomes and Postoperative Recovery in Patients With Gastric Cancer

Source: ClinicalTrials.gov · Last updated 1 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study aims to evaluate the clinical applicability of a peri-habilitation program in patients with gastric cancer by applying nutritional intervention for approximately two weeks before surgery and a combined exercise and nutrition intervention for about three weeks after hospital discharge, and by analyzing its effects on the prevention of postoperative complications and recovery.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
16 Sept 2025
Start date
15 Oct 2025
Primary completion date
30 Dec 2026
Lead sponsor
Korea University Anam Hospital
NCT number
NCT07201857

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 15 Oct 2025 to the primary completion date, 30 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with severe conditions who are unable to undergo the intervention prior to surgical treatment or chemotherapy.

Other illness

  • Patients with physical (e.g., musculoskeletal) or mental disorders that make participation in or continuation of the program impossible.

Other

  • Patients judged to be at risk of additional physical burden from the intervention.

Who the study is looking for

  • Patients aged 65 years or older who have been diagnosed with gastric cancer and are scheduled to undergo surgical treatment or chemotherapy.

Age in the registry: 65 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Anam Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.